AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,605,000 | +253.4% | 133,703 | +71.5% | 0.00% | +200.0% |
Q2 2020 | $1,303,000 | +2.9% | 77,982 | -11.1% | 0.00% | 0.0% |
Q1 2020 | $1,266,000 | -53.9% | 87,763 | +6.9% | 0.00% | -50.0% |
Q4 2019 | $2,748,000 | +126.7% | 82,124 | +41.8% | 0.00% | +100.0% |
Q3 2019 | $1,212,000 | +49.6% | 57,926 | +48.9% | 0.00% | – |
Q2 2019 | $810,000 | +145.5% | 38,900 | +163.8% | 0.00% | – |
Q1 2019 | $330,000 | +478.9% | 14,747 | +520.9% | 0.00% | – |
Q4 2018 | $57,000 | -97.7% | 2,375 | -97.3% | 0.00% | -100.0% |
Q3 2018 | $2,442,000 | +1528.0% | 89,528 | +1514.3% | 0.00% | – |
Q2 2018 | $150,000 | -80.6% | 5,546 | -77.2% | 0.00% | -100.0% |
Q1 2018 | $775,000 | -91.9% | 24,325 | -90.3% | 0.00% | -87.5% |
Q4 2017 | $9,517,000 | +592.6% | 251,628 | +353.7% | 0.01% | +700.0% |
Q3 2017 | $1,374,000 | +45700.0% | 55,463 | +53229.8% | 0.00% | – |
Q2 2017 | $3,000 | -97.3% | 104 | -98.0% | 0.00% | – |
Q1 2017 | $111,000 | +29.1% | 5,097 | +19.6% | 0.00% | – |
Q4 2016 | $86,000 | +1333.3% | 4,262 | +907.6% | 0.00% | – |
Q3 2016 | $6,000 | – | 423 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|